共 86 条
[11]
Tanner M.A.(2010)Development of thalassemic iron overload cardiomyopathy despite low liver iron levels and meticulous compliance to desferrioxamine Blood 116 537-543
[12]
Galanello R.(2008)Myocardial iron loading in patients with thalassemia major on deferoxamine chelation J Cardiaovascular Magn Reson 10 12-666
[13]
Dessi C.(2010)The effect of deferasirox on cardiac iron in thalassemia major: impact of total body iron stores Hematologica 95 557-868
[14]
Smith G.(2009)Combined chelation therapy in thalassemia major for treatment of severe myocardial siderosis with left ventricular dysfunction Therc Clin Risk Manag 5 857-465
[15]
Westwood M.A.(2009)Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion dependent anemias Eur J Haematol 82 458-764
[16]
Agus A.(2005)Update on the use of deferasirox in management of iron overload Blood 106 406-undefined
[17]
Vichinsky E.(2007)Efficacy and safety of deferasirox, an oral iron chelator, in heavily iron-overloaded patients with Indian J Pediatr 74 759-undefined
[18]
Pakbaz Z.(undefined)-thalassaemia: the ESCALATOR study undefined undefined undefined-undefined
[19]
Onyekwere O.(undefined)Myocardial T2* in patients with cardiac failure secondary to iron overload. (Abstract) undefined undefined undefined-undefined
[20]
Porter J.(undefined)Current status of iron overload and chelation with deferasirox undefined undefined undefined-undefined